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Standard treatment of optic pathways gliomas consists of radiotherapy and surgery when feasible. Owing to the toxicity of irradiation,
chemotherapy has emerged as an interesting therapeutic option, especially in young children. This study describes the
neuropsychological profile of 27 children (aged between 1.5 and 15.7 years) with optic pathways gliomas treated with chemotherapy
as first-line treatment. Eight of them also received radiotherapy as salvage treatment. Eight had neurofibromatosis type 1 (NF1).
Intellectual outcome was preserved in children treated with chemotherapy only (mean¼107717) compared to children also
receiving radiotherapy (mean IQ¼88724) or children having NF1 and treated with chemotherapy (mean IQ¼80713). Scores for
abstract reasoning, mental arithmetic, chessboard/coding, perception, judgement of line orientation were lower in children irradiated
than in those treated only by chemotherapy. Children with Nf1 showed subnormal IQ scores with marked impairment of short-
and long-term memory. With respect to long-term neuropsychological outcome, our study shows that a chemotherapy-first strategy
can preserve the intellectual outcome of these patients either by avoiding the need of radiotherapy or by delaying its use as much as
possible.
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Gliomas of the optic pathways (OPG) with or without contiguous
involvement of the hypothalamus represent 5% of all childhood
intracranial tumours (Heideman et al, 1993). The typical age of
presentation in 70% of patients is within the first decade of life and
in 90% within the first two decades. The mean age of presentation
of patients with anterior visual pathway gliomas is 8.8 years
(Dutton, 1994). Although these tumours are usually low-grade
astrocytomas, their behaviour is highly variable, ranging from
long-term stabilisation to progressive visual and neurological
impairment culminating in death (Alvord and Lofton, 1988).
Disease progression can be controlled by irradiation (Kovalic et al,
1990), but endocrinological and neurological late effects are severe
(Cappelli et al, 1998). The principal sequelae of this tumour and its
treatment consist of growth hormone deficiency and other
endocrinological deficits (Brauner et al, 1990), cognitive deficits
(Packer et al, 1983) and cerebrovascular complications (Grill et al,
1999). Moreover, when neurofibromatosis type 1 (NF1) is also
present, one may encounter additional learning difficulties (Moore
et al, 1994). Chemotherapy was introduced in the 1990s to
postpone or replace irradiation in the management of children
with this type of tumour (Packer et al, 1997). This chemother-
apeutic approach is expected to minimise the long-term side
effects compared to irradiation.
The neuropsychological profile of children treated for an OPG
has rarely been studied so far. Moreover, the benefit of a
therapeutic strategy aimed at delaying or avoiding irradiation
has not been demonstrated. The aim of this present study was to
define patterns of neuropsychological deficits in children with
optic pathway glioma treated with chemotherapy as first-line
treatment as well as the risk factors for intellectual impairment
(Laithier et al, 2003).
MATERIALS AND METHODS
Patients
All children treated first with BBSFOP chemotherapy at the Institut
Gustave Roussy (IGR), Villejuif, France, for an optic pathway
glioma were eligible for the study. Over a 1-year period, 27
children (11 boys and 16 girls) entered this cross-sectional study.
The extent of the optic pathway tumour was classified according to
Dodge classification (Dodge et al, 1958). Six patients had a Dodge
II tumour, involving the optic chiasm and one or two optic nerves;
16 had a Dodge III tumour, involving the hypothalamus or
adjacent structures. Eight had NF1 according to standard clinical
criteria (National Institute of Health consensus conference, 1988).
The patients’ age ranged from 5 months to 8.5 years (median, 1.3
Received 1 April 2003; revised 4 August 2003; accepted 12 September
2003
*Correspondence: Dr J Grill; E-mail: grill@igr.fr
British Journal of Cancer (2003) 89, 2038–2044
& 2003 Cancer Research UK All rights reserved 0007– 0920/03 $25.00
www.bjcancer.com
C
l
i
n
i
c
a
lyears) at tumour diagnosis, from 7 months to 9 years (median, 3
years) at first chemotherapy and from 1.5 to 15.7 years (median,
8.7 years) at the time of the neuropsychological assessment. Eight
patients also received irradiation as part of the treatment of a
relapse: their ages ranged from 4 to 9.11 years (median, 6.4 years)
at radiotherapy. The interval between end of chemotherapy and
the neuropsychological assessment ranged from 3 months to 9.4
years (median, 6.1 years) and from 1.1 to 5.8 years (median, 3.8
years) for children treated with radiotherapy.
Treatment
Figure 1 describes the therapeutic sequences used in the patients
who entered this study. The BBSFOP protocol consists of seven
cycles of three different courses combining either carboplatin or
natulan (course A), etoposide and cisplatin (course B) or
vincristine and cyclophosphamide (course C). The whole che-
motherapy is given over a period of one and a half years. No
irradiation was planned at the end of chemotherapy. In case of
relapse, second-line chemotherapy could be administered, usually
the vincristine–carboplatin chemotherapy as previously described
(Packer et al, 1997). Salvage treatment with irradiation had to be
postponed as much as possible, preferably after the age of 4 years.
Local irradiation was given with two beams lateral to the tumour
volume with a security margin as described previously (Cappelli
et al, 1998) until 1996, and thereafter conformal techniques with
multiple beams were used (Table 1).
Neuropsychological assessment
The neuropsychological assessment protocol included a uniform
request for evaluation of intellectual ability. Owing to the range of
patients’ ages at the time of assessment, intellectual functioning
was assessed using either the Brunet-Lezine (1997) Revised (for
children less than 3 years old, n¼6), or the age-appropriate
Wechsler scale (WPPSI-R for children less than 7 years old, n¼5
children; WISC-III for children over 7 years old, n¼16 children)
(Wechsler, 1989, 1991). Laterality was determined using the
Dellatolas protocol (De Agostini and Dellatollas, 1988). Short-term
memory was explored by the digit span (De Agostini et al. 1999).
Long-term memory was explored by the Rey auditory verbal
learning test (Rey, 1941). Oral language was evaluated by the verbal
fluency and vocabulary subtests from the WISC III. All test scores
were standardised to a mean of 10 and an s.d. of 2 using available
age norms, except for the IQ in which the scores were already
standardised to a mean of 100 and an s.d. of 15. The visual agnosia
was explored by the recognition of 80 pictures from the Snodgrass
test (Snodgrass and Vandervart, 1980) and the shape-recognition
test of the KABC (Kaufman and Kaufman 1983) (scores like
Wechsler scale). For the Snodgrass test, scores were given as a
percentage of recognised pictures: at 5 years, 100% of the pictures
should be recognised. The visual-spatial skill was assessed with the
Judgment of Line Orientation tests (Lindgren and Benton, 1980)
and scores were given in s.d. using available age norms. The visual
tests were used only in children with a preserved vision, that is, at
least four out of 10 for the best eye.
To examine perceptual skills in sensory modalities other than
vision, we created a test of tactile recognition of 10 known and 10
unknown objects. This test explores the cross-modal transfer
between touch and vision (Streri, 1993). Scores were the number of
correct answers. We also explored auditory skills with a task of
intensity discrimination and a task of modulation detection
threshold. A personal computer controlled the auditory measures.
All stimuli were delivered binaurally via an earphone at a level of
75dB SPL. Thresholds were obtained using an adaptative two-
interval, two-alternative forced-choice adaptative procedure to
evaluate the intensity or modulation necessary for 70.7% correct
detection (Hall and Grose, 1990). The latter two tests were
standardised on children at school.
The tests were timed, and a 3-h period was necessary for the
entire evaluation. Tests were always performed in the same order.
Some children were unable to perform any visual test, and they just
performed verbal and auditory tests. Information regarding school
placement, both before disease onset and at the time of
neuropsychological assessment, was also collected from interviews
with the parents.
Factors evaluated for impact on intellectual outcome
Socio-economic status (SES) was estimated from the parents’
professions and categorised into two groups: low/average and high
(Mueller and Parcel, 1981). The visual acuity was determined in all
patients. Other risk factors studied were age at diagnosis, presence
Progressive 
Tumours   
(n=27 ) BBSFOP CT 
(n=27)
PFS (n=16)
Relapse (n=11)
VINC/CARBO CT (n=6)
Relapse (n=3 ) Irradiation (n=5+3)
PFS (n=3) PFS (n=8)
Figure 1 Distribution of patients according to treatments. PFS¼pro-
progression-free survivors; VINC¼vincristine; CARBO¼carboplatin;
BBSFOP CT¼BBSFOP chemotherapy, that is, multiagent regimen of six
drugs over 16 mo.
Table 1 Radiotherapy techniques in eight children receiving irradiation as salvage treatment after failure of chemotherapy
Patients Age at diagnosis Age at irradiation Beams Technique Dose (Gy)
Last FSIQ (interval since
radiotherapy)
1 8.5 10 4 (2 antero-post, 2 lateral) Photons 18MeV 52 124 (5.5 years)
2 4 7 2 lateral Photons 4.5/18MeV 50 82 (5 years)
3 2.5 6.5 2 lateral Co60/Photons 50 81 (1 year)
4 3.5 6.5 4 (2 antero-post, 2 lateral) Photons 18MeV 50 76 (2 years)
5 1.5 4.5 4 (2 antero-post, 2 lateral) Photons 18MeV 50 56 (2 years)
6 1.5 6.5 4 non co-planar Photons 18MeV 50 98
a(3 years)
7 1 5.5 4 non co-planar Photons 18MeV 50 63
b(2 years)
8 0.5 4 8 iso-centric Photons 18MeV 50 81 (2 years)
Age is given in years. MeV¼mega-electron volt (high-energy photons); Gy¼grey.
aResults of the last evaluation (i.e. 3 years after the end of radiotherapy). For the analysis of the
results of the whole group, the previous results at 2 years were used.
bEstimation of the full-scale IQ since the patient could not perform all the visual task due to severely
impaired vision.
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Dodge staging (Dodge et al, 1958).
Statistical analysis
Statistical analysis was performed using Statistica software
(StatSoft, Guyancourt, France, 1996). Group performances were
compared using analysis of variance (ANOVA). Significant
ANOVA tests were followed up with a t-test in which the a
levels were set at 0.05. This method requires a significant F
value for the overall ANOVA and is considered to be the
most powerful of the common post hoc multiple comparison
procedures. Percentages were compared with the w
2 test. Pearson
product–moment correlations were computed in determining the
relationship between medical variables and neuropsychological
performance.
RESULTS
Study of very young children
Six children 17 months to 3.4 years old were assessed using the
Brunet-Lezine Revised scale. None of them had been irradiated
before evaluation. The median quotient was 83 (range 70–101) for
full-scale development quotient (DQ), 100 (range 74–109) for
postural development, 77 (range 52–87) for oculomotor develop-
ment, 82.5 (range 66–139) for language development and 82.5
(range 79–109) for socialisation. Ocular-motor DQ was the most
impaired in each child, while the other domains showed high
interindividual differences. For language skills, the children were
on average 6 months behind. The three children with NF1 had the
worst full-scale DQ. One of these patients had been blind since the
age of 3 months and showed global psychomotor developmental
retardation. At the time of the neuropsychological evaluation, none
of the children was attending school.
Study of older patients
A total of 21 children 4.3–15. 7 years old (median 8.7 years) passed
the WISC-III scale. The results of the neuropsychological
assessment in these 21 older patients were as follows: 10 had a
full-scale intelligence quotient (FSIQ) greater than 85, that is, in the
normal range; eight had an FSIQ between 70 and 85; and three had
an FSIQ below 70. The mean FSIQ, the verbal IQ (VIQ) and the
performance IQ (PIQ) were 92 (median 83), 97 (median 98) and 88
(median 86), respectively.
The VIQ scores of most children were usually above their PIQ
scores, with a statistically significant difference of 9 points
(P¼0.02). The mean results of the WISC III performance subtests
were around 7 (i.e. below the normal range), with a marked drop
for picture arrangement and object assembly.
Treatment with radiotherapy and the presence of NF1 were the
two risk factors for neuropsychological impairment. There was no
statistically significant correlation for the main neuropsychological
scores and the SES, age at diagnosis, extent of disease judged with
the Dodge stage and visual acuity. Verbal IQ, however, was slightly
lower in children with larger tumours (Dodge III vs Dodge II,
P¼0.05). Thus, the impact of radiotherapy and NF1 was analysed
by comparing the following three subgroups: treatment with
chemotherapy only and absence of NF1 (Group 1, n¼8),
chemotherapy followed by radiotherapy and absence of NF1
(Group 2, n¼8) and chemotherapy in children with NF1 (Group 3,
n¼5). Full-scale IQ scores were more often in the normal range in
non-NF1 children treated with chemotherapy only; 87.5% had an
IQ over 85 in group 1, 25% in group 2 and 20% in group 3,
respectively (P¼0.016, w
2 test). General intellectual functioning
was normal and higher among non-NF1 children treated with
chemotherapy alone than among those also receiving irradiation
or who had NF1 (median, 106 vs 81 vs 77, respectively) (see Table 2;
Figure 2).
For the verbal scale, children who received radiotherapy had
significantly more difficulties in abstract reasoning and vocabulary
than children treated only by chemotherapy (7.3 vs 12.6, P¼0.009;
8 vs 12.6, P¼0.008, respectively). They also had more difficulties
in arithmetic, but the difference did not reach statistical
significance (P¼0.09). Digit span performance was significantly
lower in children with NF1 than in children treated only with
chemotherapy (4.3 vs 10.5, P¼0.001) or radiotherapy (4.3 vs 9,
P¼0.008). Moreover, children with NF1 had difficulties in mental
arithmetic because of their poor working memory. Like the
children treated with radiotherapy, they tended to have more
difficulties in abstract reasoning and significantly for vocabulary
Table 2 Results of Wechsler scales in the three groups
Scores nmean (s.d.) Group 1 Chemoth. Group 2 Radioth. Group 3 NF1 Statistically significant differences
IQ scales
Full scale 107 (16.9) 87.6 (23.6) 80.4 (13.3) G1 vs G3 (P¼0.03)
Verbal 108.6 (11.9) 91 (24.8) 88.2 (19.4) NS
Performance 102 (18.9) 83.4 (19.2) 76 (11.7) G1 vs G3 (P¼0.02)
Indices
Comprehension 106.3 (10.6) 92.4 (23.3) 77.5 (0.7) NS
Perception 109.5 (16.2) 86 (17.1) 81 (5.6) G1 vs G2 (P¼0.04)
Speed 102.5 (16.1) 84.2 (16.5) 82.5 (12) G1 vs G2 (P¼0.04)
Subtests of verbal scale
Information 10.9 (2.9) 10.1 (5) 8.2 (3.5) NS
Similarities 12.6 (2.3) 7.4 (5) 8.8 (2.3) G1 vs G2 (P¼0.009)
Arithmetic 11.5 (3.5) 7.7 (4.7) 7 (4.5) NS
Vocabulary 12.6 (4.6) 8 (3.8) 8.2 (3.7) G1 vs G2 (P¼0.008), G1 vs G3 (P¼0.02)
Comprehension 10.2 (4.6) 8.9 (2.9) 8.2 (3.8) NS
Digit span 10.6 (3.1) 9 (1.7) 4.3 (0.6) G1 vs G3 (P¼0.001), G2 vs G3 (P¼0.008)
Subtests of performance scale
Picture completion 12.3 (4.5) 9.3 (4.9) 7.6 (3) NS
Block designs 12.6 (4) 8.7 (3.1) 7 (2) G1 vs G2 (P¼0.04), G1 vs G3 (P¼0.01)
Object assembly 9.3 (2.2) 6.7 (2.8) 4.6 (2.9) G1 vs G3 (P¼0.009)
Chessboard/coding 10.6 (2.1) 6.3 (4.4) 10 (2.6) G1 vs G2 (P¼0.05)
Mazes 8.2 (3.9) 5.5 (4) 6.4 (4.1) NS
Picture arrangement 8.5 (4.8) 6.3 (3) 4.7 (0.6) NS
Symbols 9.5 (3.8) 7 (2.7) 5.4 (2.3) G1 vs G3 (P¼0.04)
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lthan children treated only with chemotherapy (8.8 vs 12.6,
P¼0.07; 8.2 vs 12.6, P¼0.02, respectively).
For the performance scale, three children (one in group 1, two in
group 2) could not perform the test because of their poor visual
acuity. The children who received radiotherapy tended to have
more difficulties with chessboard/coding, object assembly and had
significantly more difficulties with block designs than children
treated only with chemotherapy (6.2 vs 10.6, P¼0.05; 6.7 vs 9.3,
P¼0.09; 6.7 vs 9.3, P¼0.04; respectively). Children treated with
radiotherapy had impaired visual-constructive abilities and slow-
ness. Symbols were also low (7 vs 9.5). The children with NF1
showed markedly impaired ability in every subtest of the
performance scale except for chessboard/coding (mean
score¼10), unlike the group of children treated with radiotherapy.
Block designs and object assembly performance were significantly
lower in children with NF1 than in children treated only by
chemotherapy (7 vs 12.6, P¼0.01; 4.6 vs 9.3, P¼0.009). Three
children passed the neuropsychological evaluation before and after
radiotherapy. Two remained with stable IQ during the first 2 years
after irradiation and one had a clear deterioration ( 13 points 4
years after irradiation).
Results of the other tests performed in older children
In every other area assessed, the mean score of the children in
group 1 was higher than in groups 2 and 3 (Table 3).
Short-term memory, explored by the digit span method, differed
significantly in the three groups (P¼0.004). Immediate recall was
normal in groups 1 and 2, with respective mean scores of 0.45s.d.
and  0.33s.d., and a low/normal range in group 3 ( 1.04s.d.).
Delayed recall was more deficient than immediate recall in groups
2 and 3, with respective mean percentages of omission of 7.39 and
20.3%. Delayed recall was significantly lower in group 3 than in
group 1 (0.48 vs 20.3%, P¼0.01). Recognition was normal for the
three groups (mean 0.14s.d.).
Performance in the Judgment of Line Orientation test was poor
and similar in groups 2 and 3 ( 1.35s.d.) relative to group 1
(0.13s.d.), but the difference was not statistically significant.
Recognition of 80 pictures in the Snodgrass test correlated with
visual acuity of the best eye (r¼0.50, p¼0.05). Considering that
100% of the pictures are recognised by children of 5 years and
above, performance was impaired for the three groups (91, 93, 83%
correct answers, for groups 1, 2 and 3, respectively), with a marked
drop for the animal category (mean score of 86%). Verbal fluency
was lower in group 2 than in group 1 (1.71 vs –0.67s.d., P¼0.05).
Shape recognition was impaired in the three groups (7.6, 6, 7.2 for
groups 1, 2 and 3 respectively), with no statistically significant
difference.
The tactile recognition test was performed by 15 children.
Tactile recognition of known objects was significantly different
(P¼0.03) in the three groups. Patients in group 3 exhibited
difficulty in recognition of known and unknown objects.
The auditory tasks were performed by 10 children. Six
children showed normal results on the two tasks. Two children
did not succeed in performing the tasks and two children, one in
group 2 and one in group 3, showed an impaired detection of
modulation associated with a normal discrimination threshold.
This profile is in agreement with a possible temporal central
deficit. These two patients had verbal deficit and a poor
comprehension of language.
School attendance at the time of the neuropsychological
evaluation was normal in 11 children, while 10 children went to
specialised schools for the blind and visually disabled. School
attendance was not statistically different in the three groups. Five
children had psychomotor therapy for the re-education of space
orientation. Seven had speech therapy (one in group 1, three in
group 2 and three in group 3).
DISCUSSION
The purpose of this study was to describe the neuropsychological
deficits in children with optic pathway glioma whose first-line
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Figure 2 IQ scores of the three groups: (A) full scale IQ; (B) verbal IQ;
(C) performance IQ. Scores represent the median value of the distribution.
Boxes represent 25–75% of the distribution. Bars represent the range, that
is, minimal and maximal values. Group 1=patients without NF-1 treated
with chemotherapy only, Group 2=patients without NF1 treated with
chemotherapy followed by radiotherapy, Group 3=patients with NF1
treated with chemotherapy only.
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ladjuvant treatment was chemotherapy, and to evaluate the effects
of salvage treatment with radiotherapy. Although these encoura-
ging results need to be confirmed in future multicentre studies,
one can consider that the goal of improving the intellectual
outcome by a chemotherapy-first study compared to irradiation
(Cappelli et al, 1998; Fouladi et al, 2003) is achievable.
The non-NF1 children treated only with chemotherapy showed a
normal mean full-scale IQ (score¼107). The mean VIQ was above
the normal range, while the mean PIQ was slightly impaired. In
most studies of radiotherapy, a significant proportion of children
had severely impaired cognitive skills (Packer et al, 1983; Silber
et al, 1992; Capelli et al, 1998). In a recent study of 31 children with
OPT, half of them treated with radiotherapy, the mean full-scale IQ
was subnormal (score ¼ 86) at diagnosis and remained stable
during follow-up (Fouladi et al, 2003).
As expected, visual-spatial skills were the most affected by the
disease and its treatment. The scores for picture recognition
(Snodgrass test) were correlated with the extent of the visual
deficit.
Even after treatment without irradiation, NF1 children with OPT
have a dismal neuropsychological prognosis. They have difficulties
with abstract reasoning, vocabulary and digit span in the verbal
scale and block designs, object assembly and symbols in the
performance scale. They also show a deficit in judgement of line
orientations, in short- and long-term memory as well as in visual
recognition. Studies of specific learning disability in children with
NF1 show intellectual impairment in as many as 40% of the
children in some series (Riccardi, 1992; North et al, 1994). Deficits
are apparent in academic achievement (spelling, arithmetic and
reading), language, visual-spatial and concentration abilities as in
our study. Eliason (Eliason, 1986) indicated that most of the
children with NF1 in his sample did not differ from the general
population in terms of verbal IQ, but had a significantly lower
performance IQ. His sample was found to have an extremely high
rate of visual-perceptual disability without evidence of OPT. To
understand the relative contribution of neurofibromatosis and
brain tumour to the cognitive profile of children with neurofi-
bromatosis, Moore et al, (1994) studied the neuropsychological
deficits of children with neurofibromatosis, brain tumour or both.
The mean scores of the neurofibromatosis–brain tumour group
were generally the lowest of the three groups; those of the brain
tumour group were highest, and performance of the neurofibro-
matosis group was generally between the other two groups. The
results indicate an increased incidence of cognitive impairment
and learning disability in children with NF1 and suggest that the
diagnosis of NF1 itself, especially in the context of a brain tumour,
is associated with a high incidence of meaningful neuropsycho-
logical deficits.
The full-scale IQ in irradiated children was lower than in
nonirradiated children. Such children had difficulties with
abstract reasoning and vocabulary in the verbal scale and
block designs, object assembly and slowness on chessboard/coding
on the performance scale. Their results in delayed recall of a
list of words and in judgement of line orientation and
verbal fluency are lower than in children treated only by
chemotherapy. However, one must consider that children receiv-
ing irradiation in our cohort had more aggressive form of
OPT with at least one relapse after chemotherapy that prompted
us to use radiotherapy. Consequently, they do not represent a
real control group for children treated with chemotherapy
only. Nevertheless, several studies on children surviving medial
edge intracranial tumours who underwent brain irradiation
showed a deterioration in a number of specific cognitive functions
(Kun and Mulhern, 1983; Packer et al, 1983; Bendersky et al,
1988; Duffner et al, 1988; Morrow et al, 1989; Garcia-Perez
et al, 1994): the most affected items were memory followed by
attention, sequential processing and visual-spatial organisational
skills. In the study of Fouladi, preschool children (i.e. before the
age of 5) had a worse intellectual outcome than older children:
mean IQ 79 vs 96, respectively, P¼0.003. Thus, our results in
patients treated with chemotherapy first compare favourably with
those obtained in children of similar age treated with radiotherapy
(mean IQ of our whole cohort¼92 compared with 79 in the study
of Fouladi). One can hope that more sophisticated irradiation
techniques such as conformal radiotherapy, intensity-modulated
radiotherapy or proton beam irradiation will cause less cognitive
damage.
The results in all 21 patients show a dissociation between a
relatively preserved verbal IQ and an impaired performance IQ
because the tumours were on the optic pathway, which would
influence the visual recognition and discrimination required to
perform some of the items on the performance subscale of the
Wechsler Intelligence for Children-Revised. The patients exhibited
poor object recognition, sometimes due to impaired visual acuity.
Thus, the diagnosis of visual agnosia cannot be clearly demon-
strated.
For the very young children, the Brunet-Lezine scale revealed
oculomotor deficit that is worsened by impaired visual acuity.
Psychomotor development, language and socialisation were in the
normal range in the absence of NF1.
Table 3 Complementary tests in the three groups
Scores Mean (SD) Group 1 Chemoth. Group 2 Radioth. Group 3 NF1 Statistically significant differences
List of words
Immediate recall 0.45 (1.3)  0.33 (1.2)  1.04 (0.8) NS
Delayed recall 0.5 (0.8) 7.4 (13.4) 20.3 (11.6) G1vsG3 (p¼0.01)
Recognition 0.07 (1.3) 0.20 (0.6) 0.16 (0.4) NS
Digit span
Digit Span Direct 0.24 (0.9)  0.24 (0.9)  0.30 (1.2) NS
Digit Span Indirect  0.07 (1.4)  0.76 (1.6)  1.40 (0.6) NS
Snodgrass test * 90.9 (6.3) 92.2 (8.7) 83.4 (18.2) NS
Benton line 0.13 (1)  1.35 (2.1)  1.35 (0.9) NS
Verbal fluency 1.71 (1.3)  0.67 (1.5) 0.07 (1.8) G1vsG2 (p¼0.05)
Shape recognition test 7.6 (3.4) 6 (4.3) 7.2 (2.9) NS
Tactile Recognition
Test A 8.9 (1.5) 9.2 (0.8) 6.3 (2) G1vsG3 and G2vsG3(p¼0.01)
Test B 5.8 (1.8) 8.8 (1.5) 5.5 (0.7) G1vsG2 (p¼0.04)
P-values correspond to a Student’s is t-test performed as post hoc analysis when ANOVA analysis indicated a statistically significant difference between the three groups.
NS¼nonsignificant; s.d.¼standard deviation. Results of the Snodgrass pictures recognition test is given as the percentage of good responses that should be 100% at 5 years. This
test was only rated for children over 5 years.
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lTactile and auditory tests were created to observe the skills in
other modalities and to find another way to evaluate children with
visual deficits. The cross-modal transfer task had showed a good
preservation of tactile recognition except for NF1 children, which
can be used for rehabilitation. Studies (Rose and Feldman, 1995;
Rose et al, 1998) have shown that this task is correlated with IQ
and we can see that children with NF1 who had difficulties in this
task had also the lowest IQ.
The auditory task was also successfully completed by all
children except for two who showed a central auditory deficit
(Hall and Grose, 1994; Lorenzi, 1999), which may explain their
verbal deficit and a bad comprehension of language (Cacace and
MacFarland, 1998). In fact, speech intelligibility depends heavily
on the accurate perception of auditory temporal envelope cues,
which is the slower amplitude modulations present in the speech
waveform (Hall and Grose, 1994; Hescot et al, 2000; Lorenzi et al,
2000).
It is thus important to obtain information with these tests in
every patient for the design of specific and individualised
rehabilitation programmes.
CONCLUSION
The neuropsychological outcome of children with optic pathway
gliomas treated by chemotherapy is preserved. Children whose
disease needed to be treated with irradiation had a worse
neuropsychological outcome, but the effect of irradiation
cannot easily be discriminated in this study from the effect
of a more severe disease course. We consider that a
thorough neuropsychological evaluation is required, together
with evaluation of visual acuity and fields in the assessment of
children treated in prospective trials. In addition to their accuracy
in discriminating treatment and comorbidity effects, these
evaluations may help to define individualised rehabilitation
programmes.
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